1. Home
  2. STOK vs AMTB Comparison

STOK vs AMTB Comparison

Compare STOK & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • AMTB
  • Stock Information
  • Founded
  • STOK 2014
  • AMTB 1979
  • Country
  • STOK United States
  • AMTB United States
  • Employees
  • STOK N/A
  • AMTB N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • AMTB Major Banks
  • Sector
  • STOK Health Care
  • AMTB Finance
  • Exchange
  • STOK Nasdaq
  • AMTB Nasdaq
  • Market Cap
  • STOK 740.9M
  • AMTB 837.4M
  • IPO Year
  • STOK 2019
  • AMTB N/A
  • Fundamental
  • Price
  • STOK $12.87
  • AMTB $19.60
  • Analyst Decision
  • STOK Strong Buy
  • AMTB Buy
  • Analyst Count
  • STOK 5
  • AMTB 4
  • Target Price
  • STOK $27.75
  • AMTB $24.00
  • AVG Volume (30 Days)
  • STOK 763.5K
  • AMTB 208.7K
  • Earning Date
  • STOK 08-06-2025
  • AMTB 07-23-2025
  • Dividend Yield
  • STOK N/A
  • AMTB 1.81%
  • EPS Growth
  • STOK N/A
  • AMTB N/A
  • EPS
  • STOK 0.88
  • AMTB 0.09
  • Revenue
  • STOK $190,908,000.00
  • AMTB $305,477,000.00
  • Revenue This Year
  • STOK $378.84
  • AMTB $57.57
  • Revenue Next Year
  • STOK N/A
  • AMTB $8.91
  • P/E Ratio
  • STOK $14.68
  • AMTB $222.62
  • Revenue Growth
  • STOK 2333.81
  • AMTB N/A
  • 52 Week Low
  • STOK $5.35
  • AMTB $16.21
  • 52 Week High
  • STOK $16.15
  • AMTB $26.24
  • Technical
  • Relative Strength Index (RSI)
  • STOK 55.63
  • AMTB 53.59
  • Support Level
  • STOK $12.25
  • AMTB $19.97
  • Resistance Level
  • STOK $14.99
  • AMTB $20.64
  • Average True Range (ATR)
  • STOK 0.83
  • AMTB 0.62
  • MACD
  • STOK -0.04
  • AMTB -0.07
  • Stochastic Oscillator
  • STOK 36.30
  • AMTB 25.53

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

Share on Social Networks: